Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484886 · ClinicalTrials.gov registry record · NA
Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT01484886 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 162 participants.
The verdict
NCT01484886, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
In neonates and infants \</= 10 kg following cardiac surgery for congenital heart disease a more restrictive red blood cell (RBC) transfusion strategy will be as effective as, and possibly superior to, a liberal RBC strategy. Allowing lower hemoglobin concentration will not affect the cardiac or pulmonary status of the patient.
Interventions
- OTHER Red blood cell transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484886
The ClinicalTrials.gov registry entry for NCT01484886 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT01484886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484886 about?
NCT01484886 is a clinical study titled "Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery". In neonates and infants \</= 10 kg following cardiac surgery for congenital heart disease a more restrictive red blood cell (RBC) transfusion strategy will be as effective as, and possibly superior to, a liberal RBC strategy. Allowing lower hemoglobin concentration will not affect the cardiac or pul...
What is the current status of trial NCT01484886?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2012-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01484886?
The interventions under investigation include: Red blood cell transfusion (OTHER).
Who is sponsoring clinical trial NCT01484886?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.